Binding of serum amyloid P component to heparin in human serum. 1994

X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
Department of Etiology/Pathophysiology, National Cardiovascular Center Research Institute, Osaka, Japan.

It has been proposed that the function of serum amyloid P component (SAP) may closely relate with its binding to polysaccharides, especially glycosaminoglycans. We employed a quantitative immunoelectrophoresis (QIE) method and a native polyacrylamide gel electrophoresis (PAGE) method to characterize the SAP-heparin binding in soluble state. The SAP-heparin binding showed positive cooperativity. The apparent numbers of heparin molecules bound to SAP varied with the calcium concentration with a ratio of 1:1 (SAP/heparin), a Kd of 2.06 x 10(-7) M at 0.1 mM CaCl2 and a ratio of 1:1.6 (SAP/heparin), a Kd of 3.91 x 10(-7) M at 2 mM CaCl2, when estimated by the QIE method. No binding between SAP and heparin was observed in the absence of calcium. Magnesium and barium failed to induce the formation of SAP-heparin complex. Furthermore, they showed inhibitory effects on the calcium-mediated complex formation. We propose that heparin might be a regulator to modulate the anticoagulant activity of SAP and a useful drug to prevent SAP deposition on amyloid deposits.

UI MeSH Term Description Entries
D008274 Magnesium A metallic element that has the atomic symbol Mg, atomic number 12, and atomic weight 24.31. It is important for the activity of many enzymes, especially those involved in OXIDATIVE PHOSPHORYLATION.
D002118 Calcium A basic element found in nearly all tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes. Coagulation Factor IV,Factor IV,Blood Coagulation Factor IV,Calcium-40,Calcium 40,Factor IV, Coagulation
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000683 Serum Amyloid P-Component Amyloid P component is a small, non-fibrillar glycoprotein found in normal serum and in all amyloid deposits. It has a pentagonal (pentaxin) structure. It is an acute phase protein, modulates immunologic responses, inhibits ELASTASE, and has been suggested as an indicator of LIVER DISEASE. Amyloid P Component,Amyloid P-Component, Serum,P Component, Amyloid,P-Component, Serum Amyloid,Serum Amyloid P Component
D001464 Barium An element of the alkaline earth group of metals. It has an atomic symbol Ba, atomic number 56, and atomic weight 138. All of its acid-soluble salts are poisonous.

Related Publications

X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
November 1994, Archives of biochemistry and biophysics,
X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
March 1987, Scandinavian journal of immunology,
X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
August 1994, European journal of biochemistry,
X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
August 1996, European journal of biochemistry,
X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
November 1995, The Journal of biological chemistry,
X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
July 2006, Electrophoresis,
X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
March 1998, Electrophoresis,
X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
May 1995, The Journal of biological chemistry,
X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
November 1979, Clinical and experimental immunology,
X A Li, and K Hatanaka, and L Guo, and Y Kitamura, and A Yamamoto
July 1991, The Journal of biological chemistry,
Copied contents to your clipboard!